Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

AtriCure (ATRC) Gross Margin (2016 - 2025)

Historic Gross Margin for AtriCure (ATRC) over the last 17 years, with Q3 2025 value amounting to 75.47%.

  • AtriCure's Gross Margin rose 5900.0% to 75.47% in Q3 2025 from the same period last year, while for Sep 2025 it was 74.87%, marking a year-over-year increase of 900.0%. This contributed to the annual value of 74.69% for FY2024, which is 5500.0% down from last year.
  • Latest data reveals that AtriCure reported Gross Margin of 75.47% as of Q3 2025, which was up 5900.0% from 74.54% recorded in Q2 2025.
  • AtriCure's Gross Margin's 5-year high stood at 76.38% during Q2 2023, with a 5-year trough of 73.97% in Q4 2022.
  • Moreover, its 5-year median value for Gross Margin was 74.88% (2024), whereas its average is 74.87%.
  • As far as peak fluctuations go, AtriCure's Gross Margin soared by 80300bps in 2021, and later plummeted by -16800bps in 2024.
  • Over the past 5 years, AtriCure's Gross Margin (Quarter) stood at 75.14% in 2021, then dropped by -2bps to 73.97% in 2022, then rose by 1bps to 74.91% in 2023, then dropped by -1bps to 74.53% in 2024, then increased by 1bps to 75.47% in 2025.
  • Its Gross Margin was 75.47% in Q3 2025, compared to 74.54% in Q2 2025 and 74.93% in Q1 2025.